Synthesis and Biological Evaluation of Furyl-Carboxamide Derivatives as Potential Anticancer Agents

Authors : Aymen ALSAMMARRA`E, Manal ALNAJDAWİ, Maysaa SALEH, Yusuf ALHİARİ, Rabab ALBASHİTİ

Pages : 909-918

Doi:10.18596/jotcsa.1092553

View : 19 | Download : 13

Publication Date : 2022-08-31

Article Type : Research Paper

Abstract :Topoisomerase II insert ignore into journalissuearticles values(Top-II); is an essential therapeutic target in cancer treatment owing to its overexpression in a wide variety of cancerous cells, including colorectal and breast cancer. Significant efforts have been made to discover and develop competitive inhibitors of the Top-II enzyme as potential anticancer agents. Herein, molecular modeling was employed to identify a new series of furyl-2-carboxamide derivatives as potential anticancer agents. Compounds 3, 5, and 7 were synthesized and characterized with the aid of several spectroscopic techniques, such as FT-IR, NMR, and mass spectroscopy, as well as elemental analysis. The anticancer activity properties of compounds 3, 5, and 7 were evaluated in vitro using an MTT assay in a human colorectal HCT-116 cell line with different concentration dilutions. The results indicate that the anthraquinone compound 3 is 1.3-1.6 times more potent against human colon cancer HCT-116 cells than the pyridine and benzophenone compounds 7 and 5, respectively, which reveals the importance of the anthraquinone moiety in exerting the inhibitory activity of the compound. Our findings recommend that further optimization of this series would benefit colon cancer treatment.
Keywords : Anticancer, furyl 2 carboxamide, docking, MTT assay, Top II